Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 103

1.

Alcohol Use in Pregnancy and Miscarriage: A Systematic Review and Meta-Analysis.

Sundermann AC, Zhao S, Young CL, Lam L, Jones SH, Velez Edwards DR, Hartmann KE.

Alcohol Clin Exp Res. 2019 Jun 13. doi: 10.1111/acer.14124. [Epub ahead of print] Review.

PMID:
31194258
2.

Building on the ACA to Achieve Universal Coverage.

Fiedler M, Aaron HJ, Adler L, Ginsburg PB, Young CL.

N Engl J Med. 2019 May 2;380(18):1685-1688. doi: 10.1056/NEJMp1901532. Epub 2019 Mar 27. No abstract available.

PMID:
31046211
3.

Impact of an Antimicrobial Stewardship Intervention on Within- and Between-Patient Daptomycin Resistance Evolution in Vancomycin-Resistant Enterococcus faecium.

Kinnear CL, Patel TS, Young CL, Marshall V, Newton DW, Read AF, Woods RJ.

Antimicrob Agents Chemother. 2019 Mar 27;63(4). pii: e01800-18. doi: 10.1128/AAC.01800-18. Print 2019 Apr.

PMID:
30718245
4.

Optimization and Lead Selection of Benzothiazole Amide Analogs Toward a Novel Antimycobacterial Agent.

De Groote MA, Jackson M, Gonzalez-Juarrero M, Li W, Young CL, Wong C, Graham J, Day J, Hoang T, Jarvis TC, Ribble W, Sun X, Ochsner UA.

Front Microbiol. 2018 Sep 20;9:2231. doi: 10.3389/fmicb.2018.02231. eCollection 2018.

5.

Discovery of benzothiazole amides as potent antimycobacterial agents.

Graham J, Wong CE, Day J, McFaddin E, Ochsner U, Hoang T, Young CL, Ribble W, DeGroote MA, Jarvis T, Sun X.

Bioorg Med Chem Lett. 2018 Oct 15;28(19):3177-3181. doi: 10.1016/j.bmcl.2018.08.026. Epub 2018 Aug 25.

PMID:
30172617
6.

Efficacy of online lifestyle interventions targeting lifestyle behaviour change in depressed populations: A systematic review.

Young CL, Trapani K, Dawson S, O'Neil A, Kay-Lambkin F, Berk M, Jacka FN.

Aust N Z J Psychiatry. 2018 Sep;52(9):834-846. doi: 10.1177/0004867418788659. Epub 2018 Jul 27.

PMID:
30052063
7.

A Model of Dormant-Emergent Metastatic Breast Cancer Progression Enabling Exploration of Biomarker Signatures.

Clark AM, Kumar MP, Wheeler SE, Young CL, Venkataramanan R, Stolz DB, Griffith LG, Lauffenburger DA, Wells A.

Mol Cell Proteomics. 2018 Apr;17(4):619-630. doi: 10.1074/mcp.RA117.000370. Epub 2018 Jan 20.

8.

Helicobacter pylori Antimicrobial Susceptibility Testing-Guided Salvage Therapy in the USA: A Real Life Experience.

Tan B, Yang JC, Young CL, Bishu S, Owyang SY, El-Zaatari M, Zhang M, Grasberger H, Qian JM, Kao JY.

Dig Dis Sci. 2018 Feb;63(2):437-445. doi: 10.1007/s10620-017-4880-8. Epub 2017 Dec 20.

PMID:
29264696
9.

Addition of transcranial direct current stimulation to quadriceps strengthening exercise in knee osteoarthritis: A pilot randomised controlled trial.

Chang WJ, Bennell KL, Hodges PW, Hinman RS, Young CL, Buscemi V, Liston MB, Schabrun SM.

PLoS One. 2017 Jun 30;12(6):e0180328. doi: 10.1371/journal.pone.0180328. eCollection 2017.

10.

Integrated Assessment of Diclofenac Biotransformation, Pharmacokinetics, and Omics-Based Toxicity in a Three-Dimensional Human Liver-Immunocompetent Coculture System.

Sarkar U, Ravindra KC, Large E, Young CL, Rivera-Burgos D, Yu J, Cirit M, Hughes DJ, Wishnok JS, Lauffenburger DA, Griffith LG, Tannenbaum SR.

Drug Metab Dispos. 2017 Jul;45(7):855-866. doi: 10.1124/dmd.116.074005. Epub 2017 Apr 27.

11.

A liver microphysiological system of tumor cell dormancy and inflammatory responsiveness is affected by scaffold properties.

Clark AM, Wheeler SE, Young CL, Stockdale L, Shepard Neiman J, Zhao W, Stolz DB, Venkataramanan R, Lauffenburger D, Griffith L, Wells A.

Lab Chip. 2016 Dec 20;17(1):156-168.

12.

Low-dose SoluMatrix diclofenac in the treatment of osteoarthritis: A 1-year, open-label, Phase III safety study.

Altman RD, Strand V, Hochberg MC, Gibofsky A, Markenson JA, Hopkins WE, Cryer B, Kivitz A, Nezzer J, Imasogie O, Young CL.

Postgrad Med. 2015 Jun;127(5):517-28. doi: 10.1080/00325481.2015.1040716. Epub 2015 Apr 27.

PMID:
25913498
13.

Recombinant G protein-coupled receptor expression in Saccharomyces cerevisiae for protein characterization.

Blocker KM, Britton ZT, Naranjo AN, McNeely PM, Young CL, Robinson AS.

Methods Enzymol. 2015;556:165-83. doi: 10.1016/bs.mie.2014.12.025. Epub 2015 Mar 20. Review.

PMID:
25857782
14.

Pharmacokinetics and safety of low-dose submicron indomethacin 20 and 40 mg compared with indomethacin 50 mg.

Olugemo K, Solorio D, Sheridan C, Young CL.

Postgrad Med. 2015 Mar;127(2):223-31. doi: 10.1080/00325481.2015.1000231. Epub 2015 Jan 31.

PMID:
25639879
15.

Pharmacokinetic properties and tolerability of low-dose SoluMatrix diclofenac.

Desjardins PJ, Olugemo K, Solorio D, Young CL.

Clin Ther. 2015 Feb 1;37(2):448-61. doi: 10.1016/j.clinthera.2014.10.018. Epub 2014 Dec 8.

PMID:
25499666
16.

Spontaneous dormancy of metastatic breast cancer cells in an all human liver microphysiologic system.

Wheeler SE, Clark AM, Taylor DP, Young CL, Pillai VC, Stolz DB, Venkataramanan R, Lauffenburger D, Griffith L, Wells A.

Br J Cancer. 2014 Dec 9;111(12):2342-50. doi: 10.1038/bjc.2014.533. Epub 2014 Oct 14.

17.

Efficacy and safety of low-dose submicron diclofenac for the treatment of osteoarthritis pain: a 12 week, phase 3 study.

Gibofsky A, Hochberg MC, Jaros MJ, Young CL.

Curr Med Res Opin. 2014 Sep;30(9):1883-93. doi: 10.1185/03007995.2014.946123. Epub 2014 Aug 6.

PMID:
25050589
18.

Protein folding and secretion: mechanistic insights advancing recombinant protein production in S. cerevisiae.

Young CL, Robinson AS.

Curr Opin Biotechnol. 2014 Dec;30:168-77. doi: 10.1016/j.copbio.2014.06.018. Epub 2014 Jul 15. Review.

19.

A microphysiological system model of therapy for liver micrometastases.

Clark AM, Wheeler SE, Taylor DP, Pillai VC, Young CL, Prantil-Baun R, Nguyen T, Stolz DB, Borenstein JT, Lauffenburger DA, Venkataramanan R, Griffith LG, Wells A.

Exp Biol Med (Maywood). 2014 Sep;239(9):1170-9. doi: 10.1177/1535370214532596. Epub 2014 May 12. Review.

20.

Approaches to in vitro tissue regeneration with application for human disease modeling and drug development.

Ebrahimkhani MR, Young CL, Lauffenburger DA, Griffith LG, Borenstein JT.

Drug Discov Today. 2014 Jun;19(6):754-62. doi: 10.1016/j.drudis.2014.04.017. Epub 2014 May 2. Review.

21.

A phase 2 study of lower-dose, indomethacin submicron particle capsules demonstrates early onset of acute pain relief.

Manvelian G, Hochberg MC, Daniels SE, Altman RD, Young CL.

Clin J Pain. 2014 Oct;30(10):846-51. doi: 10.1097/AJP.0000000000000053.

PMID:
24300220
22.

Indomethacin submicron particle capsules provide effective pain relief in patients with acute pain: a phase 3 study.

Altman R, Daniels S, Young CL.

Phys Sportsmed. 2013 Nov;41(4):7-15. doi: 10.3810/psm.2013.11.2031.

PMID:
24231592
23.

Recantation: a case study.

Young CL, Hogan L.

J Forensic Nurs. 2013 Jul-Sep;9(3):179-81. doi: 10.1097/JFN.0b013e318298fa9f.

PMID:
24158156
24.

A phase 2 study of naproxen submicron particle capsules in patients with post-surgical dental pain.

Young CL, Strand V, Altman R, Daniels S.

Adv Ther. 2013 Oct;30(10):885-96. doi: 10.1007/s12325-013-0057-9. Epub 2013 Oct 15.

PMID:
24127200
25.

Lower-dose diclofenac submicron particle capsules provide early and sustained acute patient pain relief in a phase 3 study.

Gibofsky A, Silberstein S, Argoff C, Daniels S, Jensen S, Young CL.

Postgrad Med. 2013 Sep;125(5):130-8. doi: 10.3810/pgm.2013.09.2693.

PMID:
24113671
26.

Multicenter clinical evaluation of VRESelect agar for identification of vancomycin-resistant Enterococcus faecalis and Enterococcus faecium.

Anderson NW, Buchan BW, Young CL, Newton DW, Brenke C, Lapsley L, Granato PA, Ledeboer NA.

J Clin Microbiol. 2013 Aug;51(8):2758-60. doi: 10.1128/JCM.00979-13. Epub 2013 Jun 12.

27.

Cofactor-dependent specificity of a DEAD-box protein.

Young CL, Khoshnevis S, Karbstein K.

Proc Natl Acad Sci U S A. 2013 Jul 16;110(29):E2668-76. doi: 10.1073/pnas.1302577110. Epub 2013 Apr 29.

28.

Culture-based method with performance comparable to that of PCR-based methods for detection of group B Streptococcus in screening samples from pregnant women.

Berg BR, Houseman JL, Garrasi MA, Young CL, Newton DW.

J Clin Microbiol. 2013 Apr;51(4):1253-5. doi: 10.1128/JCM.02780-12. Epub 2013 Jan 23.

29.

Analysis of ER resident proteins in Saccharomyces cerevisiae: implementation of H/KDEL retrieval sequences.

Young CL, Raden DL, Robinson AS.

Traffic. 2013 Apr;14(4):365-81. doi: 10.1111/tra.12041. Epub 2013 Feb 4.

30.

High-resolution three-dimensional reconstruction of a whole yeast cell using focused-ion beam scanning electron microscopy.

Wei D, Jacobs S, Modla S, Zhang S, Young CL, Cirino R, Caplan J, Czymmek K.

Biotechniques. 2012 Jul;53(1):41-8. doi: 10.2144/000113850.

31.

A translation-like cycle is a quality control checkpoint for maturing 40S ribosome subunits.

Strunk BS, Novak MN, Young CL, Karbstein K.

Cell. 2012 Jul 6;150(1):111-21. doi: 10.1016/j.cell.2012.04.044.

32.

Cassette series designed for live-cell imaging of proteins and high-resolution techniques in yeast.

Young CL, Raden DL, Caplan JL, Czymmek KJ, Robinson AS.

Yeast. 2012 Mar;29(3-4):119-36. doi: 10.1002/yea.2895. Epub 2012 Apr 4.

33.

Recombinant protein expression and purification: a comprehensive review of affinity tags and microbial applications.

Young CL, Britton ZT, Robinson AS.

Biotechnol J. 2012 May;7(5):620-34. doi: 10.1002/biot.201100155. Epub 2012 Jan 10. Review.

PMID:
22442034
34.

Diagnosis of Clostridium difficile infection: comparison of four methods on specimens collected in Cary-Blair transport medium and tcdB PCR on fresh versus frozen samples.

Brown NA, Lebar WD, Young CL, Hankerd RE, Newton DW.

Infect Dis Rep. 2011 May 5;3(1):e5. doi: 10.4081/idr.2011.e5. eCollection 2011 Mar 8. Review.

35.

Decreased secretion and unfolded protein response upregulation.

Young CL, Yuraszeck T, Robinson AS.

Methods Enzymol. 2011;491:235-60. doi: 10.1016/B978-0-12-385928-0.00014-6.

36.

The roles of S1 RNA-binding domains in Rrp5's interactions with pre-rRNA.

Young CL, Karbstein K.

RNA. 2011 Mar;17(3):512-21. doi: 10.1261/rna.2458811. Epub 2011 Jan 13.

37.

Pay or play programs and ERISA section 514: proposals for amending the statutory scheme.

Young CL.

Yale J Health Policy Law Ethics. 2010 Winter;10(1):197-237. No abstract available.

PMID:
20229847
38.

Progress toward heterologous expression of active G-protein-coupled receptors in Saccharomyces cerevisiae: Linking cellular stress response with translocation and trafficking.

O'Malley MA, Mancini JD, Young CL, McCusker EC, Raden D, Robinson AS.

Protein Sci. 2009 Nov;18(11):2356-70. doi: 10.1002/pro.246.

39.

Spectrum of activity and mode of action of REP3123, a new antibiotic to treat Clostridium difficile infections.

Critchley IA, Green LS, Young CL, Bullard JM, Evans RJ, Price M, Jarvis TC, Guiles JW, Janjic N, Ochsner UA.

J Antimicrob Chemother. 2009 May;63(5):954-63. doi: 10.1093/jac/dkp041. Epub 2009 Mar 3.

PMID:
19258353
40.

Inhibitory effect of REP3123 on toxin and spore formation in Clostridium difficile, and in vivo efficacy in a hamster gastrointestinal infection model.

Ochsner UA, Bell SJ, O'Leary AL, Hoang T, Stone KC, Young CL, Critchley IA, Janjic N.

J Antimicrob Chemother. 2009 May;63(5):964-71. doi: 10.1093/jac/dkp042. Epub 2009 Feb 26.

PMID:
19251726
41.

Inhibition of inositol phosphorylceramide synthase by the cyclic peptide aureobasidin A.

Aeed PA, Young CL, Nagiec MM, Elhammer AP.

Antimicrob Agents Chemother. 2009 Feb;53(2):496-504. doi: 10.1128/AAC.00633-08. Epub 2008 Dec 1.

42.

A checklist of the mosquitoes of Indiana with notes on the cryptic species complexes Anopheles quadrimaculatus s.l. and Anopheles punctipennis.

Young CL, Chaon BC, Shan QA, Lobo NF, Collins FH.

J Am Mosq Control Assoc. 2008 Sep;24(3):450-2.

PMID:
18939701
43.

Transient loss of high-level mupirocin resistance in Staphylococcus aureus due to MupA polymorphism.

Driscoll DG, Young CL, Ochsner UA.

Antimicrob Agents Chemother. 2007 Jun;51(6):2247-8. Epub 2007 Apr 16.

44.

Health resource utilization associated with switching to risperidone long-acting injection.

Young CL, Taylor DM.

Acta Psychiatr Scand. 2006 Jul;114(1):14-20.

PMID:
16774656
45.
46.

Mode of action and biochemical characterization of REP8839, a novel inhibitor of methionyl-tRNA synthetase.

Ochsner UA, Young CL, Stone KC, Dean FB, Janjic N, Critchley IA.

Antimicrob Agents Chemother. 2005 Oct;49(10):4253-62.

47.

Antibacterial activity of REP8839, a new antibiotic for topical use.

Critchley IA, Young CL, Stone KC, Ochsner UA, Guiles J, Tarasow T, Janjic N.

Antimicrob Agents Chemother. 2005 Oct;49(10):4247-52.

48.

Oral famciclovir for the suppression of recurrent genital herpes: the combined data from two randomized controlled trials.

Tyring SK, Diaz-Mitoma F, Shafran SD, Locke LA, Sacks SL, Young CL.

J Cutan Med Surg. 2003 Nov-Dec;7(6):449-54.

PMID:
15931690
49.

Early clinical experience with risperidone long-acting injection: a prospective, 6-month follow-up of 100 patients.

Taylor DM, Young CL, Mace S, Patel MX.

J Clin Psychiatry. 2004 Aug;65(8):1076-83.

PMID:
15323592
50.

A rapid, sensitive method for the quantitation of specific metabolites of sulfur mustard in human urine using isotope-dilution gas chromatography-tandem mass spectrometry.

Young CL, Ash D, Driskell WJ, Boyer AE, Martinez RA, Silks LA, Barr JR.

J Anal Toxicol. 2004 Jul-Aug;28(5):339-45.

PMID:
15239853

Supplemental Content

Loading ...
Support Center